Dr Clare Allen

Clare qualified from Oxford and is the uro-radiology lead consultant at University College London. She has pioneered the use of mpMRI (multiparametric magnetic resonance imaging) for prostate cancer since 2000 and has led the establishment of reporting standards for prostate cancer imaging in the UK. She was lead radiologist on the Promise Trial which proved the efficacy of mpMRI for prostate cancer globally.

In addition to having an interest in uro-oncology, Dr Allen has a well-developed clinical practice in dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in the prostate and is leading a team of medical physicists in further defining the role of multi-sequence MRI (magnetic resonance imaging) in diagnostic utility of prostate cancer